North America Medical Plastics Market Size, Share & Trends Analysis Report By Application, By Process Technology (Injection Molding, Extrusion, and Blow Molding & Others), By Product, By Country and Growth Forecast, 2023 - 2030

North America Medical Plastics Market Size, Share & Trends Analysis Report By Application, By Process Technology (Injection Molding, Extrusion, and Blow Molding & Others), By Product, By Country and Growth Forecast, 2023 - 2030


The North America Medical Plastics Market would witness market growth of 6.7% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 3,738.6 Kilo Tonnes, showcasing a growth of 3.0% (2019-2022).

Medical plastics are polymers whose distinctive properties and characteristics enable their use in various medical applications. These plastics have been specifically engineered to fulfill the rigorous criteria of the healthcare sector, encompassing qualities such as longevity, biocompatibility, and sterilizability. They play a crucial role in modern healthcare, enabling the development of advanced medical devices, equipment, and packaging that help improve patient outcomes and enhance the quality of care.

One of the key advantages of medical plastics is their biocompatibility, which means they are compatible with living tissue and do not induce an immune response when implanted or used in contact with the body. This makes them ideal for medical implants, such as orthopedic implants, cardiovascular devices, and dental implants, where long-term compatibility with the body is essential.

The increasing incidence of chronic illnesses in North America constitutes a substantial healthcare obstacle that propels the need for medical apparatus and devices, including those constructed from medical plastics. In the United States, nearly 60 million women (44%) have heart disease, according to the Centers for Disease Control and Prevention. Therefore, the rising prevalence of chronic diseases and the increasing aging population will present lucrative growth opportunities for the market in the coming years.

The US market dominated the North America Medical Plastics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $17,480.9 million by 2030. The Canada market is experiencing a CAGR of 9.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 8.1% during (2023 - 2030).

Based on Application, the market is segmented into Medical Components, Medical Device Packaging, Orthopedic Soft Goods, Wound Care, Cleanroom Supplies, BioPharma Devices, Mobility Aids, Sterilization & Infection Prevention, Tooth Implants, Denture Base Material and Others. Based on Process Technology, the market is segmented into Injection Molding, Extrusion, and Blow Molding & Others. Based on Product, the market is segmented into Polyphenylsulfone (PPSU), Polypropylene (PP), Polycarbonate (PC), Liquid Crystal Polymer (LCP), Polyethersulfone (PES), Polymethyl Methacrylate (PMMA), Polyethylenimine (PEI), Polyethylene (PE), and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Röchling SE & Co. KG
  • Saint-Gobain Group
  • SABIC (Saudi Arabian Oil Company)
  • Eastman Chemical Company
  • Celanese Corporation
  • The Dow Chemical Company
  • Solvay SA
  • Avantor, Inc.
  • Trinseo PLC
  • Evonik Industries AG (RAG-Stiftung)
North America Medical Plastics Market Report Segmentation

By Application (Volume, Kilo Tonnes, USD Billion, 2019-2030)
  • Medical Components
  • Medical Device Packaging
  • Orthopedic Soft Goods
  • Wound Care
  • Cleanroom Supplies
  • BioPharma Devices
  • Mobility Aids
  • Sterilization & Infection Prevention
  • Tooth Implants
  • Denture Base Material
  • Others
By Process Technology (Volume, Kilo Tonnes, USD Billion, 2019-2030)
  • Injection Molding
  • Extrusion
  • Blow Molding & Others
By Product (Volume, Kilo Tonnes, USD Billion, 2019-2030)
  • Polyphenylsulfone (PPSU)
  • Polypropylene (PP)
  • Polycarbonate (PC)
  • Liquid Crystal Polymer (LCP)
  • Polyethersulfone (PES)
  • Polymethyl Methacrylate (PMMA)
  • Polyethylenimine (PEI)
  • Polyethylene (PE)
  • Others
By Country (Volume, Kilo Tonnes, USD Billion, 2019-2030)
  • US
  • Canada
  • Mexico
  • Rest of North America


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Medical Plastics Market, by Application
1.4.2 North America Medical Plastics Market, by Process Technology
1.4.3 North America Medical Plastics Market, by Product
1.4.4 North America Medical Plastics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2022, Jul – 2024, Jan) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. North America Medical Plastics Market by Application
5.1 North America Medical Components Market by Country
5.2 North America Medical Device Packaging Market by Country
5.3 North America Orthopedic Soft Goods Market by Country
5.4 North America Wound Care Market by Country
5.5 North America Cleanroom Supplies Market by Country
5.6 North America BioPharma Devices Market by Country
5.7 North America Mobility Aids Market by Country
5.8 North America Sterilization & Infection Prevention Market by Country
5.9 North America Tooth Implants Market by Country
5.1 North America Denture Base Material Market by Country
5.11 North America Others Market by Country
Chapter 6. North America Medical Plastics Market by Process Technology
6.1 North America Injection Molding Market by Country
6.2 North America Extrusion Market by Country
6.3 North America Blow Molding & Others Market by Country
Chapter 7. North America Medical Plastics Market by Product
7.1 North America Polyphenylsulfone (PPSU) Market by Country
7.2 North America Polypropylene (PP) Market by Country
7.3 North America Polycarbonate (PC) Market by Country
7.4 North America Liquid Crystal Polymer (LCP) Market by Country
7.5 North America Polyethersulfone (PES) Market by Country
7.6 North America Polymethyl Methacrylate (PMMA) Market by Country
7.7 North America Polyethylenimine (PEI) Market by Country
7.8 North America Polyethylene (PE) Market by Country
7.9 North America Others Market by Country
Chapter 8. North America Medical Plastics Market by Country
8.1 US Medical Plastics Market
8.1.1 US Medical Plastics Market by Application
8.1.2 US Medical Plastics Market by Process Technology
8.1.3 US Medical Plastics Market by Product
8.2 Canada Medical Plastics Market
8.2.1 Canada Medical Plastics Market by Application
8.2.2 Canada Medical Plastics Market by Process Technology
8.2.3 Canada Medical Plastics Market by Product
8.3 Mexico Medical Plastics Market
8.3.1 Mexico Medical Plastics Market by Application
8.3.2 Mexico Medical Plastics Market by Process Technology
8.3.3 Mexico Medical Plastics Market by Product
8.4 Rest of North America Medical Plastics Market
8.4.1 Rest of North America Medical Plastics Market by Application
8.4.2 Rest of North America Medical Plastics Market by Process Technology
8.4.3 Rest of North America Medical Plastics Market by Product
Chapter 9. Company Profiles
9.1 Röchling SE & Co. KG
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Acquisition and Mergers:
9.1.3 SWOT Analysis
9.2 Saint-Gobain Group
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 SABIC (Saudi Arabian Oil Company)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Recent strategies and developments:
9.3.4.1 Partnerships, Collaborations, and Agreements:
9.3.4.2 Product Launches and Product Expansions:
9.3.5 SWOT Analysis
9.4 Eastman Chemical Company
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Acquisition and Mergers:
9.4.6 SWOT Analysis
9.5 Celanese Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.5.5.3 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 The Dow Chemical Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Solvay SA
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.5.3 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Avantor, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Partnerships, Collaborations, and Agreements:
9.8.4.2 Acquisition and Mergers:
9.8.5 SWOT Analysis
9.9 Trinseo PLC
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.6 SWOT Analysis
9.10. Evonik Industries AG (RAG-Stiftung)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings